Arterial stiffness: The silent marker of vascular aging
Health · Updated

Arterial stiffness: The silent marker of vascular aging

Discover what arterial stiffness is, why it is an important predictor of cardiovascular risk, and how to measure and improve it to support vascular aging.

#arterial stiffness #vascular aging #pulse wave velocity #cardiovascular health #longevity #blood pressure #atherosclerosis #biological age

Your arteries may be older than you are. A 2025 systematic review and meta-analysis published in Frontiers in Cardiovascular Medicine pooled 20 studies with 381,303 participants and found that elevated estimated pulse wave velocity (ePWV) was associated with a 3.6-fold higher risk of cardiovascular death (HR 3.64, 95% CI 2.83–4.68) and an 85% higher risk of all-cause mortality (HR 1.85, 95% CI 1.38–2.47). For every 1 m/s increase in ePWV, the risk of cardiovascular events rose by 36%. Because ePWV is calculated from age and mean blood pressure, it should be treated as a risk-stratification signal, not as a substitute for direct vascular testing.

Yet most people have never heard of this parameter. Blood pressure tells only part of the story: some people can have normal office blood pressure readings and still show higher-than-expected arterial stiffness when measured directly. Arterial stiffness is a marker that routine care can miss, yet research consistently treats it as an important predictor of cardiovascular risk and vascular aging.

The good news? Arterial stiffness is not a simple one-way process. Studies in both animal models and humans show that some components can improve with sustained changes, although advanced calcification and long-standing structural remodeling are harder to reverse.

What you will learn:

  • How arteries age and why their elasticity is crucial
  • How arterial stiffness is measured and what the reference values are
  • Scientifically validated strategies for improving vascular health
  • The connection between arterial stiffness, biological age, and longevity

Quick answer

Arterial stiffness means the large arteries have lost part of their elasticity. When directly measured PWV rises, vascular age is usually higher; when calculated ePWV rises, risk is also higher, but the value partly reflects age and blood pressure. In 2025 pooled data, each 1 m/s higher ePWV tracked with higher cardiovascular events, cardiovascular mortality, and all-cause mortality. The most practical levers are blood pressure control, aerobic training, strength work, diet quality, sleep/stress, and clinician-guided treatment.

Key facts

  • Arterial stiffness -> marker -> vascular aging: PWV captures cumulative damage that a single blood-pressure reading can miss.
  • ePWV -> risk signal -> mortality: the 2025 meta-analysis linked each 1 m/s ePWV increase to 36% higher CV events, 41% higher CV mortality, and 37% higher all-cause mortality, but ePWV is calculated rather than directly measured.
  • PWV > 10 m/s -> threshold -> organ-damage risk: European guidance treats carotid-femoral PWV above 10 m/s as a high-risk sign.
  • Lifestyle -> intervention -> partial improvement: aerobic exercise, concurrent training, weight and glucose control, and selected nutrients may improve stiffness markers, but advanced calcification is harder to reverse.

What is arterial stiffness?

Arteries are not rigid pipes: they are elastic structures that expand and contract with every heartbeat. This elasticity — called arterial compliance — allows them to buffer the pressure generated by the heart and distribute blood uniformly to the organs.

Quick definition: Arterial stiffness is the progressive loss of elasticity in the large arteries, measurable through Pulse Wave Velocity (PWV), and is an independent predictor of cardiovascular events and mortality.

With aging, arterial walls undergo structural changes: elastin fibers fragment, collagen accumulates, and vascular smooth muscle cells calcify. The result is a stiffer artery, less capable of adapting to pressure variations.

Why arterial stiffness is different from high blood pressure

Many people confuse the two concepts, but they are distinct phenomena:

Characteristic Blood pressure Arterial stiffness
What it measures Force of blood against the walls Elasticity of the walls themselves
Variability Changes minute to minute Gradual change over time
Marker of Current hemodynamic state Cumulative structural damage
Reversibility Rapid with medication Slow, requires multiple interventions

You can have a normal office blood pressure reading and still have higher-than-expected arterial stiffness. This is why blood pressure measurement alone is not enough to assess true cardiovascular health — beyond the average value, blood pressure variability is an independent risk factor that standard readings fail to capture.


The science behind arterial aging

How arteries lose elasticity

The arterial stiffening process involves multiple mechanisms that amplify each other:

Structural degeneration: Elastin fibers — responsible for the elastic “rebound” of arteries — progressively fragment. Unlike collagen, elastin has a very low turnover: the elastin produced during development must last a lifetime. When it degrades, it is replaced by stiffer collagen.

Wall calcification: Calcium deposits form in the arterial tunica media, creating zones of irreversible stiffness. This process is accelerated by vitamin K2 deficiency, kidney failure, and diabetes.

Endothelial dysfunction: The endothelium — the inner lining of arteries — loses its ability to produce nitric oxide (NO), the molecule that keeps vessels relaxed and flexible. Oxidative stress, chronic inflammation, and glycation all contribute to this dysfunction.

Chronic inflammation: Pro-inflammatory cytokines accelerate arterial wall remodeling, promoting fibrosis and calcification. Environmental noise pollution contributes to this inflammatory cascade through a distinct molecular pathway: chronic traffic noise activates NOX-2 (NADPH oxidase 2) in endothelial cells, generating reactive oxygen species that deplete nitric oxide and drive endothelial dysfunction — the same mechanism that underlies arterial stiffening. The quantified cardiovascular risk of noise pollution shows that every 10 dB increase in chronic road noise raises hypertension risk by 7–17% and coronary heart disease risk by 8% through this vascular pathway.

The cascade of consequences

When arteries stiffen, the pressure wave generated by the heart travels faster along the vessels. Normally, the reflected wave returns to the heart during diastole (the relaxation phase), aiding coronary perfusion. With stiff arteries, the reflected wave arrives during systole (the contraction phase), producing two effects:

  1. Increased cardiac workload — the heart must work harder with every beat
  2. Reduced coronary perfusion — less blood reaches the heart muscle during relaxation

Over time, this leads to left ventricular hypertrophy, heart failure, and myocardial ischemia.

Arterial stiffness and longevity: what the research shows

Arterial stiffness does not only harm the heart. Its consequences extend throughout the body:

  • Brain: Increased pulsatility in small cerebral vessels damages the microcirculation, contributing to cognitive decline and vascular dementia. A systematic review confirmed the association between arterial stiffness and worsening cognitive function in hypertensive older adults.

  • Kidneys: Hyperpulsatility damages glomerular capillaries, accelerating chronic kidney disease — which in turn worsens arterial stiffness in a vicious cycle.

  • Muscles: Poor muscle perfusion caused by arterial stiffness has been associated with sarcopenia and frailty — two key conditions of accelerated aging.

  • Legs: The same process of plaque buildup and arterial narrowing that stiffens large arteries can progressively occlude the leg arteries — a condition known as peripheral artery disease, which manifests as calf cramping with walking and dramatically elevates cardiovascular mortality risk.

  • Eyes: Hypertensive retinopathy and damage to the retinal microcirculation are correlated with stiffness in the large arteries.

Research on vascular age has identified two extreme phenotypes: Early Vascular Aging (EVA) — premature vascular aging — and SUPERNOVA — super-normal vascular aging. These phenotypes are more accurate predictors of cardiovascular risk than traditional risk factors.

2025 evidence update: The largest pooled analysis to date (Lopes et al., Frontiers in Cardiovascular Medicine, 2025 — 20 studies, 381,303 participants) found that each 1 m/s increase in estimated pulse wave velocity tracked with 41% higher cardiovascular mortality risk and 37% higher all-cause mortality risk. This strengthens ePWV as a practical risk marker, while direct carotid-femoral PWV remains the reference measurement for arterial stiffness.


How arterial stiffness is measured

Pulse Wave Velocity: the gold standard

Pulse Wave Velocity (PWV) is the reference method recommended by European hypertension guidelines. It is measured by calculating how quickly a pressure wave travels between two points in the arterial system.

How it works: A sensor records the pulse wave at the carotid artery and a second one at the femoral artery. The distance divided by the transit time gives the PWV in meters per second (m/s).

Interpreting the values:

Age Typical PWV range (m/s) Interpretation
20–40 years 5.9 ± 0.8 Elastic arteries
40–60 years 8.4 ± 1.7 Early stiffening
60–80 years 10.8 ± 2.0 Significant stiffening
Adults with risk factors > 10 m/s Hypertension-mediated organ damage marker in ESH guidance

The 2023 ESH hypertension guideline lists carotid-femoral PWV above 10 m/s as a marker of hypertension-mediated organ damage when available. The 2024 AHA Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices strengthened validation criteria for PWV devices, improving comparability across studies and manufacturers.

Other measurement methods

  • Estimated PWV (ePWV): Calculated from age and mean blood pressure using the Reference Values of Arterial Stiffness Collaboration equation. It is increasingly used in large epidemiological studies because it requires no specialized equipment, but it is a calculated risk marker rather than a direct stiffness measurement.
  • Augmentation Index (AIx): Measures the contribution of the reflected wave to central systolic pressure. A high AIx indicates stiffer arteries.
  • Arterial Stiffness Index (ASI): Available on some devices, but methods and scales differ; use validated devices and trends rather than a universal cutoff.
  • CAVI (Cardio-Ankle Vascular Index): Independent of blood pressure at the time of measurement, it is particularly useful for monitoring changes over time.

When to have arterial stiffness measured

Consider requesting a PWV measurement if you have:

  • Hypertension
  • Type 2 diabetes or insulin resistance
  • Chronic kidney disease
  • Family history of early cardiovascular events
  • Age over 50 with multiple risk factors
  • Interest in monitoring your vascular biological age

7 proven strategies to improve arterial elasticity

1. Regular aerobic exercise

Why it works: Aerobic activity is one of the best-supported non-pharmacological interventions for reducing arterial stiffness. Exercise increases nitric oxide bioavailability, reduces oxidative stress, and improves endothelial function. Studies have shown that age-related arterial stiffening is less pronounced in physically active men and women. Regular sauna use may complement training: acute sauna exposure has been shown to reduce PWV and blood pressure temporarily, and frequent sauna bathing is associated with better cardiovascular outcomes, but it should not replace exercise or medical treatment.

How to do it:

  • 150–300 minutes per week of moderate aerobic activity (brisk walking at 3.1–3.7 mph / 5–6 km/h, swimming, cycling)
  • Or 75–150 minutes of vigorous activity
  • Consistency matters more than intensity: regular moderate sessions outperform sporadic intense efforts

What to expect: PWV can improve after several weeks to months of consistent exercise, especially when blood pressure, fitness, and metabolic health improve together.

2. Combined training: aerobic + resistance (and HIIT)

Why it works: The 2025–2026 evidence is more nuanced than a blanket “HIIT is best” message: concurrent training (aerobic + resistance) looks most consistent in older adults, while a 2025 HIIT meta-analysis found modest improvements in cfPWV and stiffness indices versus continuous training or usual care. Treat HIIT as an optional tool, not a replacement for regular aerobic work.

How to do it:

  • 2–3 resistance sessions per week
  • Focus on large muscle groups with moderate loads (60–70% of one-rep max)
  • Combine with 3–4 aerobic sessions
  • Add 1–2 weekly HIIT sessions if your cardiologist clears you for vigorous exercise

What to expect: improved arterial compliance and muscle strength over months when training is consistent and appropriately prescribed.

3. A nitric oxide-rich diet

Why it works: Nitric oxide (NO) is the primary endogenous vasodilator. Increasing its bioavailability through diet improves endothelial function and reduces arterial stiffness.

How to do it:

  • Leafy green vegetables (arugula, spinach, beets) — rich in nitrates that the body converts to NO
  • Garlic — stimulates endothelial NO production
  • Pomegranate and berries — powerful antioxidants that protect NO from degradation
  • Dark chocolate (>85% cacao) — flavanols improve endothelial function
  • Reduce sodium intake below 2 g of sodium (5 g of salt) per day

What to expect: endothelial function may improve within weeks, while structural stiffness usually changes more slowly.

4. Long-chain omega-3 fatty acids

Why it works: A meta-analysis of 10 clinical trials concluded that omega-3s significantly reduce arterial stiffness. EPA and DHA exert anti-inflammatory, antioxidant, and anti-thrombotic activity that protects the arterial wall.

How to do it:

  • Fatty fish 2–3 times per week (salmon, mackerel, sardines, anchovies)
  • Target: 1–2 g/day of combined EPA+DHA from dietary sources
  • Consult your doctor about supplementation at higher doses

What to expect: some trials and meta-analyses show PWV improvements, but the effect depends on dose, baseline risk, blood pressure, and whether omega-3s replace a poor diet or are added on top of an already healthy pattern.

5. Vitamin K2 (menaquinone)

Why it works: Vitamin K2 — particularly the MK-7 form — activates matrix GLA protein, which helps inhibit vascular calcification when vitamin K status is low. A 2025 randomized controlled trial published in Nutrients (165 peri- and postmenopausal women with low vitamin K status, 180 µg/day MK-7 vs placebo for one year) found that women with heightened baseline arterial stiffness showed the clearest improvements in vascular compliance and blood pressure after MK-7 supplementation. This supports a targeted role for MK-7, not a universal anti-calcification treatment.

How to do it:

  • Fermented foods (Japanese natto — the richest source), aged cheeses, egg yolks
  • Consult your doctor about MK-7 supplementation, especially if you are on anticoagulant therapy

What to expect: possible improvement over months in people with low vitamin K status or higher baseline stiffness; avoid supplementation without medical advice if you use anticoagulants.

6. Managing chronic stress

Why it works: Chronic stress elevates cortisol levels and activates the HPA axis, promoting systemic inflammation, endothelial dysfunction, and arterial remodeling. Personality-driven chronic activation — such as cynical hostility, which keeps the nervous system in a low-grade threat state — produces the same arterial remodeling as external stressors. Regular meditation has been shown to reduce the inflammatory processes that contribute to arterial stiffening.

How to do it:

  • Mindfulness meditation for 10–20 minutes per day
  • Yoga — studies have demonstrated improved arterial stiffness, particularly in hypertensive and overweight individuals
  • Tai chi — consistently improves arterial compliance in older adults
  • Diaphragmatic breathing techniques

What to expect: reduced perceived stress and inflammatory markers within weeks, with vascular improvements depending on blood pressure, sleep, training, and baseline risk.

7. Body weight and blood sugar control

Why it works: Excess body fat — especially visceral fat — accelerates the loss of aortic elasticity. Glycation (the bonding of sugars to proteins) permanently damages collagen and elastin fibers in the arterial wall, creating AGEs (Advanced Glycation End-products) that make vessels stiff and fragile.

How to do it:

  • Maintain a BMI in the 18.5–24.9 kg/m² range (or assess body composition directly)
  • Limit added sugars and refined carbohydrates
  • Keep glycated hemoglobin (HbA1c) below 5.7%
  • Favor low-glycemic-index foods

What to expect: in humans, improvement is progressive and usually tracks the amount of weight loss, blood pressure reduction, and glucose control. Animal data show stronger reversibility than can be assumed in long-standing human vascular disease.


How to track vascular health over time

Regular monitoring is essential because arterial stiffness develops silently for years before producing symptoms.

Key metrics to monitor

Metric Tracking target Recommended frequency
Carotid-femoral PWV Age- and method-adjusted; >10 m/s is a high-risk marker in ESH guidance Annually after age 40 if risk factors are present
Carotid intima-media thickness Below 75th percentile for age/sex Every 1-2 years after age 40
Blood pressure < 120/80 mmHg Weekly (home monitoring)
Pulse pressure Often <40 mmHg in younger adults; >60 mmHg in older adults is a risk signal At every BP measurement
HRV (heart rate variability) Higher = better Daily via wearable
HbA1c < 5.7% Every 3–6 months
hsCRP (high-sensitivity C-reactive protein) < 1 mg/L Annually

Accessible indirect indicators

If you do not have access to direct PWV measurement, some indirect parameters can provide useful guidance:

  • Pulse pressure (difference between systolic and diastolic): values above 60 mmHg in older adults can suggest significant arterial stiffening
  • Isolated high systolic pressure with normal or low diastolic — a typical pattern of advanced arterial stiffness
  • Reduced HRV — often accompanies vascular dysfunction

How SuperAge helps you monitor cardiovascular health

Arterial stiffness does not develop in isolation: it is the cumulative result of blood pressure, inflammation, oxidative stress, and lifestyle. Monitoring these factors over time is key to catching the problem before it becomes advanced. For the complete framework covering all three dimensions of vascular aging — arterial stiffness, endothelial dysfunction, and atherosclerosis — see the vascular aging complete guide.

SuperAge brings together Apple Watch data and HealthKit-compatible entries for parameters that research has linked to vascular health:

  • Blood pressure — log or import values from compatible cuffs and track trends that one-off check-ups miss
  • HRV (heart rate variability) — an indicator of autonomic nervous system status, closely tied to endothelial function and vascular health
  • VO2 max — your cardiorespiratory fitness level, inversely correlated with arterial stiffness

Your biological age as an integrated indicator

Arterial stiffness accelerates biological aging. SuperAge calculates your biological age by integrating blood biomarkers and wearable data, giving you a comprehensive picture of how your body is aging — including the cardiovascular component.

Visualizing your progress

Tracking the impact of your lifestyle habits on cardiovascular health becomes straightforward: follow how your parameters change week by week and verify whether the strategies you are adopting are working.


Frequently asked questions

Is arterial stiffness reversible?

Yes, at least in part. Studies in animal models show strong reversibility after elimination of causative factors. In humans, regular aerobic exercise, weight loss, blood pressure control, and selected nutritional strategies can improve PWV or related stiffness markers. The component related to advanced calcification is more difficult to reverse.

How do I get arterial stiffness measured?

The gold standard measurement is carotid-femoral Pulse Wave Velocity (PWV), performed in a clinical setting using tonometric or oscillometric devices. Some home blood pressure monitors offer an arterial stiffness index (ASI). Ask your doctor or cardiologist for a PWV assessment, especially if you are over 50 or have risk factors.

Arterial stiffness is one of the most direct manifestations of biological aging. A person whose arteries are significantly stiffer than average for their chronological age has an accelerated “vascular age” — which is reflected in a higher biological age and greater cardiovascular risk, independent of other factors. For a detailed comparison of what each metric captures and when one matters more than the other, see our biological age vs vascular age guide.

Does normal blood pressure mean healthy arteries?

No, not necessarily. You can have normal office blood pressure and still have higher-than-expected arterial stiffness. Arterial stiffness represents accumulated structural damage, while blood pressure is an instantaneous hemodynamic measurement. In advanced stages, arterial stiffness can contribute to the isolated systolic hypertension typical in older adults.

Can exercise really improve the arteries?

Aerobic exercise is one of the best-documented interventions. Studies show that age-related stiffening is lower in physically active people. Starting later in life can still produce benefits, especially when exercise improves blood pressure, fitness, glucose control, and body composition together.


Key takeaways

  • Arterial stiffness is an independent risk marker — it can add information beyond blood pressure alone when assessing cardiovascular risk
  • It is measured with Pulse Wave Velocity (PWV) — a PWV > 10 m/s signals significant risk according to European guidelines
  • It is partly modifiable — aerobic exercise, diet quality, blood pressure control, omega-3s, targeted vitamin K2 use, and stress management can improve stiffness markers in the right context
  • It affects the whole body — not just the heart, but also the brain (cognitive decline), kidneys, muscles, and eyes
  • You can monitor related indicators — blood pressure, pulse pressure, HRV, and VO2 max are accessible with tools like SuperAge and Apple Watch

Start taking care of your arteries today

Arterial stiffness does not wait: it begins silently and progresses for years before making itself known. But now you know you are not powerless. Every exercise session, every meal rich in vascular nutrients, every restorative night of sleep contributes to keeping your arteries young.

Ready to monitor your cardiovascular health? Download SuperAge and start tracking blood pressure, HRV, and VO2 max alongside your biological age — the complete picture of your longevity.


References

  1. Vlachopoulos C. et al., “Prediction of cardiovascular events and all-cause mortality with arterial stiffness,” European Heart Journal, 2010 — Meta-analysis on PWV and mortality
  2. Mancia G. et al., “2023 ESH Guidelines for the management of arterial hypertension,” Journal of Hypertension, 2023 — PWV >10 m/s as hypertension-mediated organ damage when available
  3. Zieman S.J. et al., “Mechanisms, pathophysiology, and therapy of arterial stiffness,” Arteriosclerosis, Thrombosis, and Vascular Biology, 2005 — Pathophysiological mechanisms
  4. Tanaka H. et al., “Aging, habitual exercise, and dynamic arterial compliance,” Circulation, 2000 — Exercise and arterial compliance
  5. Knapen M.H. et al., “Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women,” Thrombosis and Haemostasis, 2015 — Vitamin K2 and arterial stiffness
  6. Pase M.P. et al., “Aortic stiffness and the risk of incident mild cognitive impairment and dementia,” Stroke, 2016 — PWV and cognitive decline
  7. Shen Y. et al., “Arterial stiffness and cognitive decline,” BMC Neurology, 2024 — Systematic review of PWV and cognition
  8. Lopes M.J. et al., “Association of estimated pulse wave velocity with cardiovascular disease outcomes and all-cause death — a systematic review and meta-analysis,” Frontiers in Cardiovascular Medicine, 2025 — Pooled analysis of 20 studies and 381,303 participants
  9. Vlachopoulos C. et al., “2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices,” Hypertension (AHA), 2024 — Updated PWV device validation standards
  10. Mansour A.G. et al., “Effects of one-year menaquinone-7 supplementation on vascular stiffness and blood pressure in post-menopausal women,” Nutrients, 2025 — RCT in 165 postmenopausal women
  11. Shaw I. et al., “Arterial stiffness adaptations to chronic resistance and aerobic exercise: a systematic review of exercise modalities,” Frontiers in Public Health, 2026 — Comparative review of exercise modalities
  12. Jiao M. et al., “Effect of HIIT on hemostasis and vascular stiffness: a systematic review and meta-analysis of randomized controlled trials”, Frontiers in Cardiovascular Medicine, 2025 — HIIT, cfPWV, and vascular stiffness meta-analysis

Last updated: 2026-07-07. This article is regularly reviewed to ensure accuracy.

The information provided does not replace professional medical advice. Consult your healthcare provider before making changes to your health routine.

Written by SuperAge Team

The SuperAge Team writes evidence-informed guides on biological age, longevity biomarkers, Apple Health, wearables, and practical healthspan tracking.